M A Pantaleo|E Palassini|R Labianca|G Biasco

Showing results (1-10 of 268) with videos related to

Pageof 27

Sort By:

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 18, 2005

Targeted therapy in colorectal cancer: do we know enough?M A Pantaleo, E Palassini, R Labianca, et al.

Minerva Medica|November 29, 2007

Targeted therapies in solid tumours: results and promisesM A Pantaleo, M Saponara, M Nannini, et al.

British Journal of Cancer|November 8, 2006

Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosaG Piazzi, P Paterini, C Ceccarelli, et al.

Cancer Treatment Reviews|March 21, 2006

Treatment of hepatic metastases from colorectal cancer: many doubts, some certaintiesG Biasco, E Derenzini, Gl Grazi, et al.

International Journal of Colorectal Disease|June 9, 2004

Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabineG Brandi, M A Pantaleo, C Calabrese, et al.

Cancer Treatment Reviews|December 7, 2007

Conventional and novel PET tracers for imaging in oncology in the era of molecular therapyM A Pantaleo, M Nannini, A Maleddu, et al.

Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 15, 2010

Molecular detection of epidermal growth factor receptor in colorectal cancer: does it still make sense?M Nannini, M A Pantaleo, P Paterini, et al.

Radiology Case Reports|February 28, 2018

Successful selective arterial embolizations for bone metastases in renal cell carcinoma integrated with systemic therapies: A case reportL Gatto, G Facchini, M Saponara, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005

Concurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreadingC Ceccarelli, G Piazzi, P Paterini, et al.

British Journal of Cancer|July 31, 2003

Hypersensitivity reactions related to oxaliplatin (OHP)G Brandi, M A Pantaleo, C Galli, et al.

Pageof 27

Showing results (1-10 of 268) with videos related to

Sort By:

Pageof 27

Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 18, 2005

Targeted therapy in colorectal cancer: do we know enough?M A Pantaleo, E Palassini, R Labianca, et al.

Minerva Medica|November 29, 2007

Targeted therapies in solid tumours: results and promisesM A Pantaleo, M Saponara, M Nannini, et al.

British Journal of Cancer|November 8, 2006

Molecular determination of epidermal growth factor receptor in normal and neoplastic colorectal mucosaG Piazzi, P Paterini, C Ceccarelli, et al.

Cancer Treatment Reviews|March 21, 2006

Treatment of hepatic metastases from colorectal cancer: many doubts, some certaintiesG Biasco, E Derenzini, Gl Grazi, et al.

International Journal of Colorectal Disease|June 9, 2004

Complete remission of primary colon cancer in a metastatic patient treated with CPT-11 plus capecitabineG Brandi, M A Pantaleo, C Calabrese, et al.

Cancer Treatment Reviews|December 7, 2007

Conventional and novel PET tracers for imaging in oncology in the era of molecular therapyM A Pantaleo, M Nannini, A Maleddu, et al.

Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|January 15, 2010

Molecular detection of epidermal growth factor receptor in colorectal cancer: does it still make sense?M Nannini, M A Pantaleo, P Paterini, et al.

Radiology Case Reports|February 28, 2018

Successful selective arterial embolizations for bone metastases in renal cell carcinoma integrated with systemic therapies: A case reportL Gatto, G Facchini, M Saponara, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2005

Concurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreadingC Ceccarelli, G Piazzi, P Paterini, et al.

British Journal of Cancer|July 31, 2003

Hypersensitivity reactions related to oxaliplatin (OHP)G Brandi, M A Pantaleo, C Galli, et al.

Pageof 27